Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram in Metastatic Melanoma
NCT00256230Phase 2Completed
- Start
- Jan 2002
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of disulfiram in melanoma. Primary endpoint: Response Rate. Started Jan 2002; status: completed.
02
Drugs
disulfiram
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00256230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256230.